Compare Cassava Sciences Inc (FLNA) vs ThredUp Inc (TDUP) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

ThredUp (TDUP) trades at $6.75, up 6.47% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with Q1 2026 revenue growth of 15% year-over-year to $81.7M and a strong gross margin of 79.4%. Recent developments include the launch of a peer-to-peer marketplace and AI-powered shopping tools. Analyst sentiment remains positive with 57% buy ratings and a $6.90 consensus price target, though the company continues to report net losses.

TDUP presents a turnaround story with improving revenue trends and cost management, but profitability remains elusive. The stock offers potential upside to analyst targets if execution continues, though risks include persistent losses, competitive pressures, and the need to achieve sustainable positive EBITDA. Current valuation at 2.58x sales appears reasonable for the growth trajectory.